Associate, Patent Attorney
Life Sciences


Ed is experienced in drafting patent applications and prosecuting them around the world, with a particular focus on the fields of immunotherapy and enzyme technology. He is also experienced in carrying out freedom-to-operate (FTO) analysis for clients looking to bring new products to market.

Areas of Expertise

  • Antibody therapeutics
  • Cell therapies and related technologies
  • Large molecule therapeutics
  • Enzyme technology
  • Diagnostics and biomarkers
  • Detection assays (particularly nucleic acid-based detection assays)


Ed works with a wide range of clients in the life sciences field from the UK and internationally, from university spin-outs and SMEs to multinational biotech corporations, and universities and research institutes.


Ed has a degree in biochemistry from the University of Oxford and a PhD in molecular microbiology from Imperial College London. His PhD research focussed on putative virulence factors in Clostridium difficile.

Ed qualified as a European and Chartered Patent Attorney in 2021, and joined Mewburn Ellis in 2022.